Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries

References

• Abid S, Hassen W, Achour A, Skhiri H, Maaroufi K, Ellouz F, Creppy E, Bacha H. (2003). Ochratoxin A and human chronic nephropathy in Tunisia: is the situation endemic? Hum Exp Toxicol 22:77–84.
   PubMed Web of Science ®Google Scholar
• Akdemir C, Ulker OC, Basaran A, Ozkaya S, Karakaya A. (2010). Estimation of ochratoxin A in some Turkish populations: an analysis in urine as a simple, sensitive and reliable biomarker. Food Chem Toxicol 48:877–882.
   PubMed Web of Science ®Google Scholar
• Aslam M, Beg AE, Blaszkiewicz M, Degen GH, Golka K. (2005). Ochratoxin A blood concentration in healthy subjects and bladder cancer cases from Pakistan. Mycotoxin Res 21:164–167.
   PubMedGoogle Scholar
• Assaf H, Betbeder AM, Creppy EE, Pallardy M, Azouri H. (2004). Ochratoxin A levels in human plasma and foods in Lebanon. Hum Exp Toxicol 23:495–501.
   PubMed Web of Science ®Google Scholar
• Battilani P, Pietri VA, Giorni P, Formenti S, Bertuzzi T, Toscani T, Virgili R, Kozakiewicz Z. (2007). Penicillium populations in dry-cured ham manufacturing plants. J Food Prot 70:975–980.
   PubMed Web of Science ®Google Scholar
• Baudrimont I. (1995). Variation de la nephrotoxicité de l’ochratoxine A sous l’effet de facteurs métaboliques et nonmétaboliques. Ph.D. thesis. Bordeaux, Université II, 1–250.
   Google Scholar
• Benford D, Boyle C, Dekant W, Fuchs R, Gaylor DW, Hard G, Mc Gregor DB, Pitt JI, Plestina R, Shepard G, Solfrizzo M, Verger PJP, Walker R. (2001). Ochratoxin A. In Safety evaluation of certain mycotoxins in food, prepared by the 56th meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA): WHO Food Additives Series 47. World Health Organization, Geneva, 47:281–387.
   Google Scholar
• Bendele AM, Carlton WW, Krogh P, Lillehoj EB. (1985). Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J Natl Cancer Inst 75:733–742.
   PubMed Web of Science ®Google Scholar
• Biasucci G, Calabrese G, Di Giuseppe R, Carrara G, Colombo F, Mandelli B, Maj M, Bertuzzi T, Pietri A, Rossi F. (2011). The presence of ochratoxin A in cord serum and in human milk and its correspondence with maternal dietary habits. Eur J Nutr 50:211–218.
   PubMed Web of Science ®Google Scholar
• Bogs C, Battilani P, Geisen R. (2006). Development of a molecular detection and differentiation system for ochratoxin A producing Penicillium species and its application to analyse the occurrence of Penicillium nordicum in cured meats. Int J Food Microbiol 107:39–47.
   PubMed Web of Science ®Google Scholar
• Breitholtz-Emanuelsson A, Hult K. (1991a). Enzyme-linked immunosorbent assay for analysis of ochratoxin A in human plasma samples using antibodies raised against a new ochratoxin –protein conjugate.. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, ed. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours IARC Scientific Publications. Lyon, France: IARC, 115:89–92.
   Google Scholar
• Breitholtz A, Olsen M, Dahlbäck A, Hult K. (1991b). Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam 8:183–192.
   PubMed Web of Science ®Google Scholar
• Breitholtz-Emanuelsson A, Olsen M, Oskarsson A, Palminger I, Hult K. (1993). Ochratoxin A in cow’s milk and in human milk with corresponding human blood samples. J AOAC Int 76:842–846.
   PubMed Web of Science ®Google Scholar
• Breitholtz-Emanuelsson A, Minervini F, Hult K, Visconti A. (1994). Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Nat Toxins 2:366–370.
   PubMedGoogle Scholar
• Bunge I, Dirheimer G, Röschenthaler R. (1978). In vivo and in vitro inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A. Biochem Biophys Res Commun 83:398–405.
   PubMed Web of Science ®Google Scholar
• Burdaspal PA, Legarda TM. (1998). Datos sobre la presencia de ochratoxina A en plasma humano en Espana. Alimentaria 292:103–109.
   Google Scholar
• Castegnaro M, Canadas D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A. (2006). Balkan endemic nephropathy: role of ochratoxins A through biomarkers. Mol Nutr Food Res 50:519–529.
   PubMed Web of Science ®Google Scholar
• Chopra M, Link P, Michels C, Schrenk D. (2010). Characterization of ochratoxin A-induced apoptosis in primary rat hepatocytes. Cell Biol Toxicol 26:239–254.
   PubMed Web of Science ®Google Scholar
• Coronel MB, Marin S, Tarrago M, Cano-Sancho G, Ramos AJ, Sanchis V.. (2011). Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain. Food Chem Toxicol 49:1436–1442.
   PubMed Web of Science ®Google Scholar
• Creppy EE, Størmer FC, Kern D, Röschenthaler R, Dirheimer G. (1983). Effects of ochratoxin A metabolites on yeast phenylalanyl-tRNA synthetase and on the growth and in vivo protein synthesis of hepatoma cells. Chem Biol Interact 47:239–247.
   PubMed Web of Science ®Google Scholar
• Creppy EE, Castegnaro M, Grosse Y, Mériaux J, Moncharmont P, Waller C et al. (1993). Etude de l’ochratoxicose humaine dans trois régions de France: Alsace, Aquitaine, et région Rhône – Alpes.. In: Creppy EE, Castegnaro M, Dirheimer G. ed. Human ochratoxicosis and its Pathologies. United Kingdom: Colloque INSERM/John Libbey Eurotext, London, 231:147–158.
   Google Scholar
• Degen GH, Mayer S, Blaszkewicz M. (2007). Biomonitoring of ochratoxin A in grain workers. Mycotoxin Res 23:88–93.
   PubMedGoogle Scholar
• Dinis AM, Lino CM, Pena AS. (2007). Ochratoxin A in nephropathic patients from two cities of central zone in Portugal. J Pharm Biomed Anal 44:553–557.
   PubMed Web of Science ®Google Scholar
• Domijan AM, Peraica M, Fuchs R, Lucic A, Radic B, Balija M, Bosanac I, Grgicevic D. (1999). Ochratoxin A in blood of healthy population in Zagreb. Arh Hig Rada Toksikol 50:263–271.
   PubMedGoogle Scholar
• Duarte S, Bento J, Pena A, Lino CM, Delerue-Matos C, Oliva-Teles T, Morais S, Correia M, Oliveira MB, Alves MR, Pereira JA. (2010). Monitoring of ochratoxin A exposure of the Portuguese population through a nationwide urine survey–Winter 2007. Sci Total Environ 408:1195–1198.
   PubMed Web of Science ®Google Scholar
• Duarte SC, Pena A, Lino CM. (2011). Human ochratoxin a biomarkers–from exposure to effect. Crit Rev Toxicol 41:187–212.
   PubMed Web of Science ®Google Scholar
• Dostal A, Cajdova J, Jakusova L, Hudeckova H. (2007). First results of the pilot study of OTA in breast milk in Slovakia. Pediatria 2:319–321 (in Slovak).
   Google Scholar
• EFSA. (2006). Opinion of the scientific panel on contaminants in the food chain on request from the commission related to ochratoxin A in food. EFSA J 365:1–56.
   Google Scholar
• El-Sayed AM, Soher EA, Neamat-Allah AA. (2002). Human exposure to mycotoxins in Egypt. Mycotoxin Research 18:23–30.
   PubMedGoogle Scholar
• Erkekoglu P, Sabuncuoglu S, Aydin S, Sahin G, Giray B. (2010). Determination of seasonal variations in serum ochratoxin A levels in healthy population living in some regions of Turkey by enzyme-linked immunosorbent assay. Toxicon 55:507–513.
   PubMed Web of Science ®Google Scholar
• European Union. (2002). Assessment of dietary intake of ochratoxin A by the population of EU member states. Report of experts participating in Task 3.2.7 Reports on Tasks for Scientific Cooperation. Available at: http://ec.europa.eu/food/fs/scoop/ index_en.html. Accessed on 15 July 2009.
   Google Scholar
• Filali A, Betbeder AM, Baudrimont I, Benayad A, Soulaymani R, Creppy EE. (2002). Ochratoxin A in human plasma in Morocco: a preliminary survey. Hum Exp Toxicol 21:241–245.
   PubMed Web of Science ®Google Scholar
• Fournier E. (1993). Toxicologie. Nephrotoxines. Paris: Ellipses, 473–485.
   Google Scholar
• Frisvad JC, Frank JM, Houbraken JAMP, Kuijpers AFA, Samson RA. (2004). New ochratoxin A producing species of Aspergillus section Circumdati. Studies in Mycology 50:23–43.
   Google Scholar
• Fuchs R, Radic B, Ceovic S, Sostaric B, Hult K. (1991). Human exposure to ochratoxin A. IARC Sci Publ., No. 115:131–134.
   Google Scholar
• Fukal L, Reisnerova H. (1990). Monitoring of aflatoxins and ochratoxin A in Czechoslovak human sera by immunoassay. Bull Environ Contam Toxicol 44:345–349.
   PubMed Web of Science ®Google Scholar
• Gareis M, Märtlbauer E, Bauer J, Gedek B. (1988). [Determination of ochratoxin A in human milk]. Z Lebensm Unters Forsch 186:114–117.
   PubMedGoogle Scholar
• Gareis, Rosner H, Ehrhardt S (2000). Blood serum levels of ochratoxin A and nutrition habits. Arch Lebensmittelhyg 51:108–110.
   Google Scholar
• Gilbert J, Brereton P, MacDonald S. (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam 18:1088–1093.
   PubMed Web of Science ®Google Scholar
• Golinski P, Grabatkiewicz-Szczenasna J, Chelkowski J, Hult K, Kostecki M. (1991). Possible sources of ochratoxin A in human blood.. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H. ed. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. IARC Scientific Publications. Lyon, France:IARC, 115:153–157.
   Google Scholar
• Grajewski J, Jarzemski P, Twaruzek M, Kuzminska K, Trepala M. (2007). The level of ochratoxin A in patients after nephrectomy. Mycotoxin Res 23:22–26.
   PubMedGoogle Scholar
• Grosse Y, Monje MC, Mace K, Pfeifer A, Pfohl-Leszkowicz A. (1997). Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of ochratoxin A. Toxicol in Vitro 10:93–102.
   Google Scholar
• Grosso F, Saíd S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S. (2003). New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 41:1133–1140.
   PubMed Web of Science ®Google Scholar
• Gürbay A, Girgin G, Sabuncuoglu SA, Sahin G, Yurdakok M, Yigit S, Tekinalp G. (2009). Ochratoxin A: is it present in breast milk samples obtained from mothers from Ankara, Turkey. Toxicol Lett 189:232–236.
   Web of Science ®Google Scholar
• Guzmán EM, Guerrero FA, Chaves JA. (2007). [Ocratoxin A in human plasma and coffee from Costa Rica by ELISA]. Arch Latinoam Nutr 57:168–172.
   PubMed Web of Science ®Google Scholar
• Hadlok RM, Wagner G. (1993). Vorkommen von ochratoxin A beim menschen in Deutschland. Fleischwirtsch 73:1079–1080.
   Google Scholar
• Hagelberg S, Hult K, Fuchs R. (1989). Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J Appl Toxicol 9:91–96.
   PubMed Web of Science ®Google Scholar
• Hald B. (1991). Ochratoxin A in human blood in European countries. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H . (ed) Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon, France: IARC, 115:159–164.
   Google Scholar
• Halliwell B. (1991). Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am J Med 91 (suppl 3C), 14–22.
   Google Scholar
• Hassan AM, Sheashaa HA, Fattah MF, Ibrahim AZ, Gaber OA, Sobh MA. (2006). Study of ochratoxin A as an environmental risk that causes renal injury in breast-fed Egyptian infants. Pediatr Nephrol 21:102–105.
   PubMed Web of Science ®Google Scholar
• Hassen W, Abid S, Achour A, Creppy E, Bacha H. (2004). Ochratoxin A and beta2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the centre of Tunisia: a hot spot of Ochratoxin A exposure. Toxicology 199:185–193.
   PubMed Web of Science ®Google Scholar
• Haubeck HD, Lorkowski G, Kölsch E, Röschenthaler R. (1981). Immunosuppression by ochratoxin A and its prevention by phenylalanine. Appl Environ Microbiol 41:1040–1042.
   PubMed Web of Science ®Google Scholar
• Hmaissia Khlifa K, Ghali R, Mezigh C, Aouni Z, Ghorbel H, Harrzallah K, Machgoul S, Hedhili A.. (2008). Serum levels of ochratoxin A in healthy subjects and in nephropathic patients in Tunisia. Ann Biol Clin (Paris) 66:631–636.
   PubMed Web of Science ®Google Scholar
• Hult K, Plestina R, Habazin-Novak V, Radic B, Ceovic S. (1982). Ochratoxin A in human blood and Balkan endemic nephropathy. Arch Toxicol 51:313–321.
   Web of Science ®Google Scholar
• IARC. (1993). Monographs on the evaluation of carcinogenic risks to humans: Some naturally occuring substances: Food items and costituents, heterocyclic aromatic amines and mycotoxins. Lyon, France: IARC, 56:489–524.
   Google Scholar
• Jimenez AM, de Cerain AL, Gonzales-Penas E, Bello J, Betbeder AM, Creppy EE. (1998). Exposure to ochratoxin A in Europe: Comparison with a region of nothern Spain. J Toxicol Toxin Reviews 17:479–491.
   Web of Science ®Google Scholar
• Jonsyn FE, Maxwell SM, Hendrickse RG. (1995). Ochratoxin A and aflatoxins in breast milk samples from Sierra Leone. Mycopathologia 131:121–126.
   PubMed Web of Science ®Google Scholar
• Jonsyn FE. (1999). Intake of aflatoxins and ochratoxins by infants in Sierra Leone: Possible effects on the general health of these children. J Nutr Environ Med 9:15–22.
   Google Scholar
• Jonsyn-Ellis FE. (2000). Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girls. Mycopathologia 152:35–40.
   Web of Science ®Google Scholar
• Jørgensen K. (2005). Occurrence of ochratoxin A in commodities and processed food–a review of EU occurrence data. Food Addit Contam 22 Suppl 1:26–30.
   PubMedGoogle Scholar
• Karima HK, Ridha G, Zied A, Chekib M, Salem M, Abderrazek H. (2010). Estimation of Ochratoxin A in human blood of healthy Tunisian population. Exp Toxicol Pathol 62:539–542.
   PubMed Web of Science ®Google Scholar
• Kanisawa M, Suzuki S. (1978). Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin. Gann 69:599–600.
   PubMedGoogle Scholar
• Khalef A, Zidane C, Charef A, Gharbi A, tadjerouna M, Betbeder AM, Creppy EE. (1993). Ochratoxicoses humaines en Algérie.. In: Creppy E, Castegnaro M, Dirheimer G. ed. Human ochratoxicosis and its pathologies. Paris:John Libbey Eurotext. 231:123–127.
   Google Scholar
• Konrad I, Röschenthaler R. (1977). Inhibition of phenylalanine tRNA synthetase from Bacillus subtilis by ochratoxin A. FEBS Lett 83:341–347.
   PubMed Web of Science ®Google Scholar
• Krogh P, Gyrd-Hansen N, Hald B, Larsen S, Nielsen JP, Smith M, Ivanoff C, Meisner H. (1988). Renal enzyme activities in experimental ochratoxin A-induced porcine nephropathy: diagnostic potential of phosphoenolpyruvate carboxykinase and gamma-glutamyl transpeptidase activity. J Toxicol Environ Health 23:1–14.
   PubMed Web of Science ®Google Scholar
• Krogh P. (1992). Role of ochratoxin in disease causation. Food Chem Toxicol 30:213–224.
   PubMed Web of Science ®Google Scholar
• Kuiper-Goodman T, Ominski K, Marquardt RR, Malcom S, McMullen E, Lombaert GA, Morton T. (1993). Estimating human exposure to ochratoxin A in Canada.. In: Creppy EE, Castegnaro M, Dirheimer G. ed. Human ochratoxicosis and its pathologies. INSERM/John Libbey Eurotext, Montrouge, France, 167–174.
   Google Scholar
• Kuiper-Goodman T, Hilts C, Billiard SM, Kiparissis Y, Richard ID, Hayward S. (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27:212–240.
   PubMed Web of Science ®Google Scholar
• Larsen JC. (1995). Levels of pollutants and their metabolites: exposures to organic substances. Toxicology 101:11–27.
   PubMed Web of Science ®Google Scholar
• Larsen TO, Svendsen A, Smedsgaard J. (2001). Biochemical characterization of ochratoxin A-producing strains of the genus Penicillium. Appl Environ Microbiol 67:3630–3635.
   PubMed Web of Science ®Google Scholar
• Li S, Marquardt RR, Frohlich AA. (2000). Identification of ochratoxins and some of their metabolites in bile and urine of rats. Food Chem Toxicol 38:141–152.
   PubMed Web of Science ®Google Scholar
• Maaroufi K, Achour A, Hammami M, el May M, Betbeder AM, Ellouz F, Creppy EE, Bacha H. (1995). Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol 14:609–614.
   PubMed Web of Science ®Google Scholar
• Maaroufi K, Achour A, Betbeder AM, Hammami M, Ellouz F, Creppy EE, Bacha H. (1995). Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol 69:552–558.
   PubMed Web of Science ®Google Scholar
• Mac Donald SJ, Langton S, Brereton PA. (2001). Assessment of human oxposure to ochratoxin A in the UK- Relationship between dietary intake and plasma and urine.. In: de Koe WJ, Samson RA, van Egmond HP, Gilbert J, Sabino M. ed. Mycotoxins and phycotoxins in perspective at the turn of the millenium. Wageningen:WJ de Koe, 181–188.
   Google Scholar
• Malir F, Cerna M, Severa J, Jergeova Z. (1998a). Ochratoxin A - toxicological importance, exposure of humans and health risk. Hygiena 43:49–62. (in Czech)
   Google Scholar
• Malir F, Brndiar M, Roubal T, Severa J, Fixa P, Kacerovsky J, Zahradnik J, Osterreicher J, Knizek J, Cerna M. (2001a). A Study of the Accumulation of Ochratoxin A in Patients with Chronic Renal Insufficiency (CHRI) in the Czech Republic. Mycotoxin Res 17:39–44.
   PubMedGoogle Scholar
• Malir F, Roubal T, Brndiar M, Osterreicher J, Severa J, Knizek J, Kacerovsky J, Tmejova M, Betbeder AM, Baudrimont I, Crepppy EE. (2001b). Ochratoxin A in the Czech Republic. J Toxico.-Toxin Reviews 20:261–274.
   Web of Science ®Google Scholar
• Malir F, Severa J, Roubal T, Kacerovsky J, Fixa P, Moucka P, Zahradnik J, Knizek J, Osterreicher J, Brndiar M, Cerna M. (2001c). The Dialysis of ochratoxin A (OTA). Mycotoxin Res 17A:129–131.
   Google Scholar
• Malir F, Ostry V. (eds.) (2003). Moulds, mycotoxins and public health. NCONZO, Brno. (In Czech).
   Google Scholar
• Malir F, Ostry V, Grosse Y, Roubal T, Skarkova J, Ruprich J. (2006). Monitoring the mycotoxins in food and their biomarkers in the Czech Republic. Mol Nutr Food Res 50:513–518.
   PubMed Web of Science ®Google Scholar
• Malir F, Roubal T, Brndiar M, Kacerovsky J, Pacovsky J, Moravek P, Melichar B, Malirova E, Cerna M. (2008). The monitoring mycotoxins and their potential impact on human health: ochratoxin A. (in Czech). In: Proceedings of 4. Seminary with International Participation. Mycotoxins 2008. Prague: Crop Research Institute, 27–36.
   Google Scholar
• Manderville RA. (2005). A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction. Chem Res Toxicol 18:1091–1097.
   PubMed Web of Science ®Google Scholar
• Manderville RA, Pfohl-Leszkowicz A. (2008). Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycotox J 1:357–367.
   Web of Science ®Google Scholar
• Manique R, Pena A, Lino CM, Moltó JC, Mañes J. (2008). Ochratoxin A in the morning and afternoon portions of urine from Coimbra and Valencian populations. Toxicon 51:1281–1287.
   PubMed Web of Science ®Google Scholar
• Märtlbauer E, Usleber E, Dietrich R, Schneider E. (2009). Ochratoxin A in human blood serum- retrospective long-term data. Mycotox Res 25:175–186.
   PubMedGoogle Scholar
• Mayura K, Reddy RV, Hayes AW, Berndt WO. (1976). Teratogenic and toxic effects of ochratoxin A in rats. Toxicol Appl Pharmacol 37:331–338.
   PubMed Web of Science ®Google Scholar
• Miraglia M, Brera C, Colatosti M. (1996). Application of Biomarkers to Assessment of Risk to Human Health from Exposure to Mycotoxins. Microchem J 54:472–477.
   Web of Science ®Google Scholar
• Muñoz K, Vega M, Rios G, Muñoz S, Madariaga R. (2006). Preliminary study of Ochratoxin A in human plasma in agricultural zones of Chile and its relation to food consumption. Food Chem Toxicol 44:1884–1889.
   PubMed Web of Science ®Google Scholar
• Muñoz K, Campos V, Blaszkewicz M, Vega M, Alvarez A, Neira J, Degen G. (2010). Exposure of neonates to ochratoxin A: first biomonitoring results in human milk (colostrum) from Chile. Mycotox Res 26:59–67.
   PubMedGoogle Scholar
• Ozçelik N, Kosar A, Soysal D. (2001). Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol Lett 121:9–13.
   PubMed Web of Science ®Google Scholar
• Ostry V, Malir F, Roubal T, Skarkova J, Ruprich J, Cerna M, Creppy EE. (2005). Monitoring of mycotoxin biomarkers in the Czech Republic. Mycotoxin Res 21:49–52.
   PubMedGoogle Scholar
• Ostry V, Skarkova J, Kavrik R, Ruprich J. (2010a). An occurrence of ochratoxin A and aflatoxin M1 biomarkers in human urine.. In: 32th Mycotoxin Workshop. Lyngby, Denmark:Society for Mycotoxin Research, 145.
   Google Scholar
• Ostry V, Skarkova J, Malir F, Ruprich J. (2010b). An occurrence of ochratoxin A, a biomarker of dietary exposure, in human biological materials.. In: Proceedings of 6. Seminary with International Participation. Mycotoxins 2010. Prague: VSCHT, 32–40.
   Google Scholar
• Pacin AM, Ciancio Bovier EV, Motta E, Resnik SL, Villa D, Olsen M. (2008). Survey of Argentinean human plasma for ochratoxin A. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25:635–641.
   PubMed Web of Science ®Google Scholar
• Palli D, Miraglia M, Saieva C, Masala G, Cava E, Colatosti M, Corsi AM, Russo A, Brera C. (1999). Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomarkers Prev 8:265–269.
   PubMed Web of Science ®Google Scholar
• Pena A, Seifrtová M, Lino C, Silveira I, Solich P. (2006). Estimation of ochratoxin A in portuguese population: new data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection. Food Chem Toxicol 44:1449–1454.
   PubMed Web of Science ®Google Scholar
• Peraica M, Domijan AM, Fuchs R, Lucic A, Radic B. (1999). The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett 110:105–112.
   PubMed Web of Science ®Google Scholar
• Peraica M, Domijan AM, Matasin M, Lucic A, Radic B, Delas F, Horvat M, Bosanac I, Balija M, Grgicevic D. (2001). Variations of ochratoxin A concentration in the blood of healthy populations in some Croatian cities. Arch Toxicol 75:410–414.
   PubMed Web of Science ®Google Scholar
• Pérez de Obanos A, López de Cerain A, Jimenez AM, Gonzales-Penas E, Bello J. (2001). Ochratoxin A in human plasma: new data of exposition in Spain. Rev Toxicol 18:19–23.
   Google Scholar
• Perrone G, Mulè G, Susca A, Battilani P, Pietri A, Logrieco A. (2006a). Ochratoxin A production and amplified fragment length polymorphism analysis of Aspergillus carbonarius, Aspergillus tubingensis, and Aspergillus niger strains isolated from grapes in Italy. Appl Environ Microbiol 72:680–685.
   PubMed Web of Science ®Google Scholar
• Perrone G, Susca A, Epifani F, Mulè G. (2006b). AFLP characterization of Southern Europe population of Aspergillus Section Nigri from grapes. Int J Food Microbiol 111 Suppl 1:S22–S27.
   Google Scholar
• Petkova-Bocharova T, Castegnaro M. (1985). Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit Contam 2:267–270.
   PubMed Web of Science ®Google Scholar
• Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. (1988). Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit Contam 5:299–301.
   PubMedGoogle Scholar
• Petkova-Bocharova T, Castegnaro M. (1991). Ochratoxin A in human blood in relation to endemic nephropathy and urinary tract tumors in Bulgaria.. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H. ed. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon: IARC 115:159–164.
   Google Scholar
• Petkova-Bocharova T, Castegnaro M, Pfohl-Leszkowicz A, Garren L, Grosso F, Nikolov I, Vrabcheva T, Dragacci S, Chernozemsky IN. (2003). Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan endemic nephropathy: a one – month follow up study. Facta Univ Series Med Biol 10:62–68.
   Google Scholar
• Pfohl-Leszkowicz A, Vrabcheva T, Petkova-Bocharova T, Garren L, Grosso F, Nikolov I, Dragacci S, Chernozemsky IN, Castegnaro M. (2004). Analysis of ochratoxin a in serum, urine and food consumed by inhabitants from an area with Balkan endemic nephropathy: a one month follow up study.. In: Njapau H, Trujillio S, Van Egmond HP, Park DL . ed. Mycotoxins and phycotoxins. Proceeding of the XIth International IUPAC Symposium on Mycotoxins and Phycotoxins, May 17–21, 2004, Bethesda, Maryland, USA; Wageningen:Academic Publishers, 217–224.
   Google Scholar
• Pfohl-Leszkowicz A, Tozlovanu M, Stepanovic J, Stefanovic V, Manderville R, Castegnaro M. (2006). Comparative genotoxicity of ochratoxin A and aristolochic acid in human kidney cells: Interpretation of ongoing analyses of food, blood, urine and kidney tissue from Serbia. Colleg Antropologic Suppl 30, 1–17.
   Google Scholar
• Pfohl-Leszkowicz A, Manderville RA. (2007). Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51:61–99.
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. (2007). New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res 51:1131–1146.
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A. (2009). Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 60:465–483.
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Manderville RA. (2012). An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity. Chem Res Toxicol 25:252–262.
   PubMed Web of Science ®Google Scholar
• Rahimtula AD, Chong X. (1991). Alteration in calcium homeostasis as a possible cause of ochratoxin A nephrotoxicity.. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H. ed. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon: IARC 115:207–214.
   Google Scholar
• Report on carcinogens. (2011). Twelfth Edition: 335–337, 2011. Available at: http://ntp.niehs.nih.gov./go/roc 12. Accessed on 14 December 2011
   Google Scholar
• Rösner H, Rohrmann B, Peiker G. (2000). Ochratoxin A in human serum. Arch Lebensmittelhyg 51:104–107.
   Web of Science ®Google Scholar
• Ruprich J, Ostrý V. (1993a). Study of human exposure to ochratoxin A and assessment of possible sources. Cent Eur J Public Health 1:46–48.
   PubMedGoogle Scholar
• Ruprich J, Ostrý V. (1993b). Health risk assessment of the mycotoxin ochratoxin A to humans: Czech Republic–Brno–1991/92. Cent Eur J Public Health 1:86–93.
   PubMedGoogle Scholar
• Samson RA, Houbraken JAMP, Kuijpers AFA, Frank JM, Frisvad JC. (2004). New ochratoxin A or sclerotium producing species in Aspergillus section Nigri. Studies in Mycology 50:45–46.
   Google Scholar
• Sangare-Tigori B, Moukha S, Kouadio JH, Dano DS, Betbeder AM, Achour A, Creppy EE. (2006). Ochratoxin A in human blood in Abidjan, Côte d’Ivoire. Toxicon 47:894–900.
   PubMed Web of Science ®Google Scholar
• Schwerdt G, Freudinger R, Silbernagl S, Gekle M. (1999). Ochratoxin A-binding proteins in rat organs and plasma and in different cell lines of the kidney. Toxicology 135:1–10.
   PubMed Web of Science ®Google Scholar
• Scott PM, Kanhere SR, Lau BP, Lewis DA, Hayward S, Ryan JJ, Kuiper-Goodman T. (1998). Survey of Canadian human blood plasma for ochratoxin A. Food Addit Contam 15:555–562.
   PubMedGoogle Scholar
• Scott PM. (2005). Biomarkers of human exposure to ochratoxin A. Food Addit Contam 22 Suppl 1:99–107.
   PubMedGoogle Scholar
• Skaug MA, Helland I, Solvoll K, Saugstad OD. (2001). Presence of ochratoxin A in human milk in relation to dietary intake. Food Addit Contam 18:321–327.
   PubMed Web of Science ®Google Scholar
• Solti L, Salamon F, Barna-Vetró I, Gyöngyösi A, Szabó E, Wölfling A. (1997). Ochratoxin A content of human sera determined by a sensitive ELISA. J Anal Toxicol 21:44–48.
   PubMed Web of Science ®Google Scholar
• Steyn PS. (1993). Mycotoxins of human health concern.. In: Creppy EE, Castegnaro M, Dirheimer G. ed. Human ochratoxicosis and its Pathologies. London, United Kingdom: Colloque INSERM/John Libbey Eurotext, 231:3–31.
   Google Scholar
• Stoev SD. (2010). Studies on carcinogenic and toxic effects of ochratoxin A in chicks. Toxins (Basel) 2:649–664.
   PubMed Web of Science ®Google Scholar
• Stojkovic R, Hult K, Gamulin S, Plestina R. (1984). High affinity binding of ochratoxin A to plasma constituents. Biochem Int 9:33–38.
   PubMedGoogle Scholar
• Studer-Rohr I, Schlatter J, Dietrich DR. (2000). Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol 74:499–510.
   PubMed Web of Science ®Google Scholar
• Tapai K, Teren J, Mesterhazy A. (1997). Ochratoxin A in the sera of blood donors and ill persons. Cereal Res Commun 25:307–308.
   Web of Science ®Google Scholar
• Thuvander A, Paulsen JE, Axberg K, Johansson N, Vidnes A, Enghardt-Barbieri H, Trygg K, Lund-Larsen K, Jahrl S, Widenfalk A, Bosnes V, Alexander J, Hult K, Olsen M. (2001). Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 39:1145–1151.
   PubMed Web of Science ®Google Scholar
• Timbrell JA. (1998). Biomarkers in toxicology. Toxicology 129:1–12.
   PubMed Web of Science ®Google Scholar
• Turconi G, Guarcello M, Livieri C, Comizzoli S, Maccarini L, Castellazzi AM, Pietri A, Piva G, Roggi C. (2004). Evaluation of xenobiotics in human milk and ingestion by the newborn–an epidemiological survey in Lombardy (Northern Italy). Eur J Nutr 43:191–197.
   PubMed Web of Science ®Google Scholar
• Ueno Y, Maki S, Lin J, Furuya M, Sugiura Y, Kawamura O. (1998). A 4-year study of plasma ochratoxin A in a selected population in Tokyo by immunoassay and immunoaffinity column-linked HPLC. Food Chem Toxicol 36:445–449.
   PubMed Web of Science ®Google Scholar
• van der Merwe KJ, Steyn PS, Fourie L, Scott DB, Theron JJ. (1965). Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205:1112–1113.
   PubMed Web of Science ®Google Scholar
• Vukelic M, Sostaric B, Belicza M. (1992). Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol 30:193–200.
   PubMed Web of Science ®Google Scholar
• Wafa EW, Yahya RS, Sobh MA, Eraky I, el-Baz M, el-Gayar HA, Betbeder AM, Creppy EE. (1998). Human ochratoxicosis and nephropathy in Egypt: a preliminary study. Hum Exp Toxicol 17:124–129.
   PubMed Web of Science ®Google Scholar
• Wu Q, Dohnal V, Huang L, Kuca K, Wang X, Chen G, Yuan Z. (2011). Metabolic pathways of ochratoxin A. Curr Drug Metab 12:1–10.
   PubMed Web of Science ®Google Scholar
• Zepnik H, Völkel W, Dekant W. (2003). Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol Appl Pharmacol 192:36–44.
   PubMed Web of Science ®Google Scholar
• Zimmerli B, Dick R. (1995). Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J Chromatogr B, Biomed Appl 666:85–99.
   PubMed Web of Science ®Google Scholar